In a recent ruling, a federal judge in Manhattan denied Bayer’s attempt to stop Johnson & Johnson from advertising its prostate‑cancer drug, Erleada. The court said Bayer had not shown it was likely to win the case over J&J’s marketing, which claimed Erleada cuts death risk by about half compared to
Doctors have two common tools to guess if prostate cancer will come back after surgery. One tool, CAPRA, looks at PSA numbers, how fast the cancer is growing, and whether it has spread. The other, called CAPRA-S, does the same but after the tumor is removed. Both tools are handy, but they ignore the
A 70‑year‑old man who has beat prostate cancer twice now stands in a clinic lobby to help men who have just been told they might have the same disease. He sits on the third floor of a urology practice in Charlotte, North Carolina, where he gives out handouts about symptoms, support groups and hea
Prostate cancer is a serious health issue for many men. Doctors often use a method called active surveillance to monitor it. This means they keep a close eye on the cancer instead of treating it right away. But how do they decide who is a good fit for this approach? One tool that might help is the
Prostate cancer is a tough nut to crack. It often becomes resistant to treatments, and the side effects can pile up. So, scientists are always on the lookout for new ways to fight it. Curcumin and piperine are two natural compounds that have shown promise. They can target cancer cells directly. But
Prostate cancer is a serious health issue. Doctors often use a procedure called robot-assisted radical prostatectomy (RARP) to treat it. This method is quite effective, but sometimes, cancer cells are left behind. This is known as a positive surgical margin (PSM). It happens in about one out of five
Radiotherapy for prostate cancer is getting a major upgrade. Doctors are now using shorter treatment plans, known as hypofractionated schedules, which deliver higher doses in fewer sessions. This approach is not only more convenient but also shows promise in reducing side effects. However, it's not
Prostate cancer is tricky. It can hide, especially the most dangerous type, Grade Group 5 (GG5). Doctors often miss it during biopsies. That's why finding better ways to detect it is important. One tool that might help is the Cell Cycle Progression (CCP) score. It could point out hidden GG5 cancer.
Scott Adams, the creator of the famous Dilbert cartoons, has been dealing with serious health issues. Recently, he revealed that he is now paralyzed from the waist down due to prostate cancer that has spread to his bones. Adams shared this news on social media, saying he can't move his muscles but
Prostate cancer is a serious issue. It affects many men. Former UK Prime Minister David Cameron is one of them. He recently shared his story. He hopes it will help others. Cameron is 59 years old. He found out he had prostate cancer. His wife encouraged him to get tested. He took a PSA test. This t
